Bioptik Technology (4161) — Financial Flexibility Index
Bioptik Technology (4161) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of NT$58.15 Million (operating CF NT$53.21 Million minus capex NT$4.94 Million) represents 0% of total liabilities (NT$597.14 Million). Check 4161 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bioptik Technology Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Bioptik Technology across 9 annual periods. For the full cash flow conversion analysis, see Bioptik Technology (4161) cash flow conversion.
Annual Financial Flexibility Index for Bioptik Technology (2017–2025)
Year-by-year free cash flow to debt coverage for Bioptik Technology. Explore how well can Bioptik Technology service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | NT$82.79 Million | NT$59.99 Million | NT$597.14 Million | ▼ -53.7% |
| 2024 | 0.30x | NT$174.33 Million | NT$158.82 Million | NT$582.47 Million | ▼ -14.9% |
| 2023 | 0.35x | NT$236.99 Million | NT$205.95 Million | NT$673.56 Million | ▲ +288.9% |
| 2022 | 0.09x | NT$72.14 Million | NT$55.06 Million | NT$797.40 Million | ▲ +451.8% |
| 2021 | -0.03x | NT$-21.33 Million | NT$-41.15 Million | NT$829.38 Million | ▼ -196.1% |
| 2020 | 0.03x | NT$19.75 Million | NT$6.57 Million | NT$738.10 Million | ▼ -69.3% |
| 2019 | 0.09x | NT$68.46 Million | NT$41.03 Million | NT$786.05 Million | ▼ -25.7% |
| 2018 | 0.12x | NT$92.78 Million | NT$41.83 Million | NT$792.07 Million | ▲ +7.7% |
| 2017 | 0.11x | NT$73.74 Million | NT$11.02 Million | NT$678.08 Million | — |